Table 2.

HLA-DPB1 mismatches and classification as permissive or nonpermissive in UD-recipient pairs from this study




HLA-DPB1
Classification* and UPN
Outcome
Recipient
Donor
Permissive (n = 24)    
   1   —   0201   0201,0401  
   2   —   0201,0402   0201,0401  
   3   —   0401   0101,0401  
   4   —   0401,1101   0401,0402  
   5   —   0401   0401,0402  
   6   R   0201,0401   0401  
   7   R   0401   0201,0401  
   8   III  0301,1701  0401,1701 
   9   —   0201,0402   0402,1101  
   10   —   0201,0401   0401  
   11   —   0201,0402   0201,0401  
   12   —  0301,0402  0301,0401  
   13   II   0201,0301 0301,0401  
   14   —   0401   0401,0402  
   15   II   0201   0401  
   16   —   0402   0202,0401  
   17   —   0401   0201  
   18   —   0201   0401,0402  
   19   —  1401 0301 
   20   —   0101   0101,0401  
   21   —   0402,1601   0201,0401  
   22   —   0401,0402   0201,0401  
   23   II   0402   0402,1101  
   24   II  0301,0401   0201,0301 
Nonpermissive HvG (n = 17)    
   25   II   0401,2401§ 0301,0401  
   26   R   0201,0401   0201,0301 
   27   II   0401   00301,0401  
   28   II   0201,0401  0301,0401  
   29   —   0401,0402  0301,0402  
   30   —   0201,0401  0301,0401  
   31   —   0401,0402   0401,1001 
   32   II   0201  0301,0402  
   33   IV   0201  0301,0401  
   34   R   0401,0402   0201,0301 
   35   R   0201,1501   0401,1401 
   36   II, R   0401  0301,1301  
   37   —   0401,0601  1001,2301  
   38   —  0301,0401  1001 
   39   —   0201  0301,0401  
   40   II   0201,0401  0301,1701 
   41   IV   0201  0301,0401  
Nonpermissive GvH (n = 10)    
   42   R   0401,1001 0301,0401  
   43   —   0201,0301  0201  
   44   III   0401,1001  0401,0501  
   45   —  0301,0401   0401,0402  
   46   —   1101,1701  0101,1101  
   47   —  0301,1701  0401,0402  
   48   III  1001 0301,1601  
   49   III  0301,0402   0401  
   50   —  0301,0401   0401  
   51
 
II
 
0401,1001
 
0402,2001
 



HLA-DPB1
Classification* and UPN
Outcome
Recipient
Donor
Permissive (n = 24)    
   1   —   0201   0201,0401  
   2   —   0201,0402   0201,0401  
   3   —   0401   0101,0401  
   4   —   0401,1101   0401,0402  
   5   —   0401   0401,0402  
   6   R   0201,0401   0401  
   7   R   0401   0201,0401  
   8   III  0301,1701  0401,1701 
   9   —   0201,0402   0402,1101  
   10   —   0201,0401   0401  
   11   —   0201,0402   0201,0401  
   12   —  0301,0402  0301,0401  
   13   II   0201,0301 0301,0401  
   14   —   0401   0401,0402  
   15   II   0201   0401  
   16   —   0402   0202,0401  
   17   —   0401   0201  
   18   —   0201   0401,0402  
   19   —  1401 0301 
   20   —   0101   0101,0401  
   21   —   0402,1601   0201,0401  
   22   —   0401,0402   0201,0401  
   23   II   0402   0402,1101  
   24   II  0301,0401   0201,0301 
Nonpermissive HvG (n = 17)    
   25   II   0401,2401§ 0301,0401  
   26   R   0201,0401   0201,0301 
   27   II   0401   00301,0401  
   28   II   0201,0401  0301,0401  
   29   —   0401,0402  0301,0402  
   30   —   0201,0401  0301,0401  
   31   —   0401,0402   0401,1001 
   32   II   0201  0301,0402  
   33   IV   0201  0301,0401  
   34   R   0401,0402   0201,0301 
   35   R   0201,1501   0401,1401 
   36   II, R   0401  0301,1301  
   37   —   0401,0601  1001,2301  
   38   —  0301,0401  1001 
   39   —   0201  0301,0401  
   40   II   0201,0401  0301,1701 
   41   IV   0201  0301,0401  
Nonpermissive GvH (n = 10)    
   42   R   0401,1001 0301,0401  
   43   —   0201,0301  0201  
   44   III   0401,1001  0401,0501  
   45   —  0301,0401   0401,0402  
   46   —   1101,1701  0101,1101  
   47   —  0301,1701  0401,0402  
   48   III  1001 0301,1601  
   49   III  0301,0402   0401  
   50   —  0301,0401   0401  
   51
 
II
 
0401,1001
 
0402,2001
 

UPN indicates unique patient number; —, neither GVHD nor rejection.

*

Classification of HLA-DPB1 mismatches as permissive or nonpermissive in HvG or GvH direction, according to the algorithm we previously described13 

Outcome of each patient receiving a transplant in terms of occurrence of graft rejection (R) or acute GvHD grade II (II), III (III), or IV (IV), defined according to the criteria stated in “Patients and methods”

Complete typing of HLA-DPB1 alleles present in the recipient and in the donor. Immunogenicity groups of HLA-DPB1 alleles according to the algorithm we previously described13  are indicated as follows: group 1, highly immunogenic (underlining); group 2, intermediately immunogenic (italics); group 3, poorly immunogenic (normal typeface)

§

HLA-DPB1*2401 was assigned to group 3 of nonimmunogenic alleles on the basis of amino acid sequence homology with DPB1*4601, the prototype of group 3 alleles, and not as all other alleles, on the basis of functional studies using alloreactive T lymphocytes13 

or Create an Account

Close Modal
Close Modal